UCB S.A. is seeking a Health Economic & Outcomes Research Strategy Lead to shape global HEOR strategies and payer evidence across the product lifecycle.
You will influence development programs and collaborate with cross-functional teams to support successful payer access and reimbursement decisions. The role offers hybrid work arrangements with 40% office time, and opportunities to contribute to value dossiers, publication activities, and international collaboration across markets including the
#J-18808-Ljbffr
Global HEOR Strategy Lead — Payer & HTA (Hybrid) in Reading employer: UCB S.A.
UCB S.A. is an exceptional employer that fosters a collaborative and innovative work culture, particularly in the field of immunology. With a strong commitment to employee growth and development, you will have access to unique opportunities for professional advancement while working in a hybrid environment that promotes work-life balance. Join us in making a meaningful impact on patient outcomes across the UK and Ireland, where your contributions will be valued and recognised.
